Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Mind Medicine (MindMed) Inc N.MMED.WR


Primary Symbol: MNMD Alternate Symbol(s):  N.MMED.WS | N.MMED.WA | N.MMED

Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM-120 and MM-402, the Company's product candidates. MM120, is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that it is developing for the treatment of generalized anxiety disorder (GAD). MM-120 is also being studied in a subperceptual repeat administration dosing regimen for the treatment of attention deficit hyperactivity disorder (ADHD). MM-402, also referred to as R(-)-MDMA, is the Company's form of the R-enantiomer of 3,4-methylenedioxymethampheta (MDMA), which the Company is developing for the treatment of autism spectrum disorder (ASD).


NDAQ:MNMD - Post by User

Post by BillyKnowsBeston Jan 21, 2021 3:33pm
233 Views
Post# 32350916

Psychedelics, Airline and Theaters

Psychedelics, Airline and TheatersI give my take on all three sectors, with heavy emphasis on psychedelics in this weeks episode of Sector Rapid Fire

I called that today was the day for MMED to break out, and sure enough it did!

I love this stock, and think you can keep riding it. The next level of resistance I see is at thr $4.55 level. If we can break that I see $5 in the near future!!

Give it a listen if you've got 10 minutes!!

In yesterday's episode we covered the airline sector; Air Canada, Delta Airlines & American Airlines

We address the recent earnings report from United Airlines which shook weakness through the entire sector, and I give price targets for all three. 

Check it out if you've got 10 minutes!

https://anchor.fm/10-minute-investing
<< Previous
Bullboard Posts
Next >>